Researchers at KAUST and Peking University Third Hospital have created a novel blastoid model for studying early human development using extended pluripotent stem cells (EPSCs). The blastoid is a 3D cell model mimicking the blastocyst phase, avoiding ethical concerns associated with using human embryos. The team showed that blastoids can be cultured to mimic post-implantation development, offering insights into early cell lineages. Why it matters: This innovation provides a way to study human embryogenesis without the ethical constraints of using actual embryos, potentially advancing our understanding of miscarriage and birth defects.
Khaled Alsayegh at the King Abdullah International Medical Research Center is creating a Saudi Stem Cell Donor Registry, with 80,000 potential donors identified. The aim is to identify universal donors, reprogram their cells into induced pluripotent stem (iPS) cells, and create a gene bank for matched tissue transplants. Alsayegh is collaborating with Jesper Tegnér at KAUST to create pacemaker cells using single-cell RNA sequencing. Why it matters: This initiative could revolutionize precision medicine in KSA by providing readily available, matched cells for transplants, reducing the need for patient-specific reprogramming and improving treatment outcomes.
KAUST researchers led by Dr. Niveen Khashab have developed thermosensitive liposomes for controlled drug release, particularly in cancer therapies. The liposomes are designed to release drugs only when they reach heated tumor tissue, minimizing systemic side effects. Cholesterol moieties are used as anchors to create a "nail" or "comb" effect, enabling temperature-triggered drug release inside cells. Why it matters: This targeted drug delivery system could significantly improve the efficacy and reduce the toxicity of cancer treatments.
The Khaleej Times article discusses the potential Initial Public Offerings (IPOs) of leading technology companies like Anthropic, OpenAI, and SpaceX. It examines how these future public listings could enrich UAE investors, including sovereign wealth funds, who have already invested in these firms. The UAE has strategically positioned itself as a major investor in global tech and AI, potentially yielding significant financial returns from these high-profile companies. Why it matters: This highlights the UAE's deep financial integration into the global AI and technology landscape and its potential to benefit substantially from the growth of leading international tech giants.
Dr. Giampiero Marchegiani from the Quantum Research Center (QRC) co-authored a paper in Nature Nanotechnology on bipolar thermoelectricity in Josephson junctions. The research demonstrates the generation of electrical current using heat, observing bipolar thermoelectricity where the device generates either positive or negative electrical signals without extra control. Integrating these junctions into a bipolar thermoelectric Josephson engine (BTJE) allowed the generation of up to ~140nW/mm2 of electric power at subkelvin temperatures. Why it matters: This BTJE engine may have applications in superconducting technology, potentially strengthening the UAE's position in quantum technologies.
KAUST hosted the inaugural in-person World Intellectual Property Organization (WIPO) Summer School in Saudi Arabia, in partnership with the Saudi Authority on Intellectual Property (SAIP). The summer school brought together 40 participants of 22 nationalities along with 10 international and local speakers. Participants covered topics such as copyright, patents, trademarks, and technology transfer. Why it matters: This event signals Saudi Arabia's commitment to building an innovation culture and strengthening IP rights in line with Vision 2030.
KAUST postdoctoral fellow Elisabetta Fiacco won the Best Poster Prize at the Spetses Summer School 2018 on Chromatin and Metabolism for her research on the role of carbohydrate-responsive element binding protein (ChRBP) during the onset of type 2 diabetes. Fiacco's research at KAUST, under Assistant Professor Antonio Adamo, uses human induced pluripotent stem cells to understand the epigenetic and transcriptional mechanisms dysregulated in type 2 diabetes. She also gave a 15-minute oral presentation on her work at the event, which gathered over 80 participants from top global universities. Why it matters: This recognition highlights KAUST's contribution to cutting-edge research in regenerative medicine and the study of metabolic disorders prevalent in the region.
KAUST's Laboratory of Stem Cells and Diseases, led by Assistant Professor Antonio Adamo, uses induced pluripotent stem cells (iPSCs) to model diseases like diabetes. The lab employs a reprogramming technique to revert patient fibroblasts into iPSCs, enabling the study of disease progression in vitro. Adamo's research focuses on enzymes and disregulated transcriptional/epigenetic mechanisms to understand disease onset. Why it matters: This research contributes to regenerative medicine and offers insights into metabolic diseases relevant to the GCC region.